Why the study?
Does remote monitoring reduce hospital readmissions and agency costs compared to standard of care in heart failure patients receiving home health care?
Does remote monitoring reduce hospital readmissions and agency costs compared to standard of care in heart failure patients receiving home health care?
Remote monitoring in a heart failure home health care program did not reduce hospital readmissions and increased agency costs compared to standard of care, making it not financially viable.
Remote monitoring showed no readmission link; leaves open whether it reduces visits or costs in retrospective home health data.
In this study, we examine the cost per outcomes of remote monitoring services in home health care. The methodology followed case matched design via retrospective chart reviews. Results of the chi-square test suggest that there were no significant associations between the intervention and hospital readmissions, χ2 = (1, n = 210, p-value = .71, phi = .71). An independent t-test compared group means of the number of skilled nursing visits and agency costs, p-value of .002 and .000, respectively, favoring the standard of care group. Based on this data set, the home care agency lost $153.46 for each hospital readmission in the intervention group. The cost of care complicated the agency’s resources through an increase in nursing visits without offsetting the agency’s investment into technology; the cost did not support remote monitoring as a financially viable option to the standard of care.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: